LIGAND PHARMACEUTICALS INCORPORATED Accrued Sales Commission
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Accrued Sales Commission of $3.99 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedSalesCommissionCurrentAndNoncurrent · last filed 2023-02-28
- 2022-12-31: Accrued Sales Commission $3.99M.
- 2021-12-31: Accrued Sales Commission $630.00K.
- 2020-12-31: Accrued Sales Commission $421.00K.
- 2019-12-31: Accrued Sales Commission $381.00K.
| Period end | Accrued Sales Commission |
|---|---|
| 2022-12-31 | $3.99M 10-K · filed 2023-02-28 |
| 2021-12-31 | $630.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | $421.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $381.00K 10-K · filed 2021-02-24 |
| 2018-12-31 | $428.00K 10-K · filed 2020-02-27 |
| 2017-12-31 | $396.00K 10-K · filed 2019-02-28 |
| 2016-12-31 | $899.00K 10-K · filed 2018-03-01 |
| 2015-12-31 | $915.00K 10-K · filed 2017-02-28 |
| 2014-12-31 | $925.00K 10-K · filed 2016-11-14 |
| 2013-12-31 | $651.00K 10-K · filed 2015-02-23 |